Track Cresco Labs Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Cresco Labs Inc. CRLBF Open Cresco Labs Inc. in new tab

0.9650 USD
EPS
-0.38
P/B
0.88
ROE
-43.72
Beta
1.64
Cresco Labs Inc. logo

Cresco Labs Inc.

🧾 Earnings Recap – Q3 2025

Cresco Labs reported a modest revenue growth of 1% to $165 million in Q3 2025 while making strategic moves to strengthen the balance sheet and focus on core markets for sustainable growth.

  • Adjusted EBITDA reached $40 million, reflecting disciplined execution and a focus on cash-generating operations.
  • Completed debt refinancing, enhancing financial flexibility and positioning for future investments and M&A opportunities.
  • Exited California operations, reducing liabilities and organizational complexity to concentrate on more profitable ventures.
  • Maintained #1 retail share in Ohio with successful new dispensary openings planned for early 2026, while preparing to enter Kentucky's medical market.
  • Set to launch flagship Cresco branded products in Germany, marking the company's entry into the European Union market.
📅
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateMay 20, 2026
EPS-0.38
Book Value0.95
Price to Book0.88
Debt/Equity231.35
% Insiders2.101%
Growth
Revenue Growth-0.08%
Estimates
Forward P/E-7.55
Forward EPS-0.11

DCF Valuation

Tweak assumptions to recompute fair value for Cresco Labs Inc. (CRLBF)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Cresco Labs Inc. Logo Cresco Labs Inc. Analysis (CRLBF)

United States Health Care Official Website Stock

Is Cresco Labs Inc. a good investment? Cresco Labs Inc. (CRLBF) is currently trading at 0.9650 USD.

Earnings Schedule: Cresco Labs Inc. is expected to release its next earnings report on May 20, 2026. The market consensus estimate for Forward EPS is -0.11.

Investor FAQ

Does Cresco Labs Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Cresco Labs Inc.?

Cresco Labs Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be May 20, 2026. The company currently has a trailing EPS of -0.38.

Company Profile

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes, gummies, and pre-rolls under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers cannabis flowers under the FloraCal brand; and cannabis oils and variety of bites are available at multiple potency levels under the Mindy's brand, as well as Loud*r brand. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company is headquartered in Chicago, Illinois.

Exchange Ticker
PNK (United States) CRLBF
CNQ (Canada) CL.CN

Dividends

Historical Split Corporate Actions

Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion